Cocrystal Pharma Inc.

COCP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.22

+$0.01 (+0.83%)

At close: Sep 21, 2026, 3:59 PM ET

$1.19

-$0.03 (-2.46%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	105K	225K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	91K	-1.39M	954K	21K	1.36M	28K	3.24M	4.31M	2.95M	4.27M	4.19M	2.8M	3.91M	3.29M	3.87M	2.36M	2.87M	97K	2.11M	2.56M	1.58M
Gross Profit	105K	134K	1.39M	-954K	-21K	-1.36M	-28K	-3.24M	-4.31M	-2.95M	-4.27M	-4.19M	-2.8M	-3.91M	-3.29M	-3.87M	-2.36M	-2.87M	-97K	-2.11M	-2.56M	-1.58M
Operating Income	-3.18M	-2.36M	-2.48M	-2.09M	-2.11M	-2.34M	-3.23M	-5.04M	-5.45M	-4.16M	-4.67M	-4.44M	-4.34M	-5.11M	-4.5M	-5.69M	-24.43M	-4.21M	-3.7M	-3.95M	-3.83M	-2.74M
Interest Income	10K	22K	-87K	22K	28K	37K	55K	111K	151K	220K	180K	320K	140K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-3.16M	-2.3M	-2.43M	-2.05M	-2.06M	-2.3M	-3.27M	-4.94M	-5.34M	-3.96M	-4.46M	-4.17M	-4.17M	-5.19M	-4.5M	-5.7M	-24.43M	-4.21M	-3.69M	-3.94M	-3.82M	-2.74M
Net Income	-3.16M	-2.3M	-2.43M	-2.05M	-2.06M	-2.3M	-3.27M	-4.94M	-5.34M	-3.96M	-4.46M	-4.17M	-4.17M	-5.19M	-4.5M	-5.7M	-24.43M	-4.21M	-3.69M	-3.94M	-3.82M	-2.74M
Selling & General & Admin	1.15M	1.21M	862K	1.14M	986K	981K	1.17M	1.8M	1.14M	1.21M	1.4M	1.85M	1.54M	1.2M	1.22M	1.82M	1.38M	1.33M	1.4M	1.85M	1.27M	1.16M
Research & Development	2.14M	1.37M	1.62M	954K	1.12M	1.36M	2.04M	3.24M	4.31M	2.95M	4.27M	4.19M	2.8M	3.91M	3.29M	3.87M	2.36M	2.87M	2.21M	2.11M	2.56M	1.58M
Other Expenses	n/a	-91K	1.39M	-954K	-21K	-1.36M	n/a	-3.24M	-4.31M	-2.95M	-5.27M	-5.79M	-2.8M	-3.91M	-3.29M	-3.87M	18.33M	-2.87M	n/a	-2.11M	-2.56M	-1.58M
Operating Expenses	3.29M	2.49M	3.88M	1.14M	2.09M	981K	3.2M	1.8M	1.14M	1.21M	399K	249K	1.54M	1.2M	1.22M	1.82M	22.07M	1.33M	3.61M	1.85M	1.27M	1.16M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	78K	1K	1K	n/a	1K	n/a	1K	2K	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	39K	n/a	n/a	n/a	55K	n/a	n/a	n/a	22K	n/a	n/a	n/a	19K	n/a	n/a	n/a	19K
Cost & Expenses	3.29M	2.58M	2.48M	2.09M	2.11M	2.34M	3.23M	5.04M	5.45M	4.16M	4.67M	4.44M	4.34M	5.11M	4.5M	5.69M	24.43M	4.21M	3.7M	3.95M	3.83M	2.74M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	13.79M	13.79M	11.29M	10.99M	10.17M	10.17M	10.17M	10.17M	10.17M	10.17M	10.17M	10.15M	10.07M	8.14M	8.14M	8.14M	8.12M	8.12M	7.26M	8.12M	7.26M	5.94M
Shares Outstanding (Diluted)	13.79M	13.79M	11.29M	10.99M	10.17M	10.17M	10.17M	10.17M	10.17M	10.17M	10.17M	10.15M	10.07M	8.14M	8.14M	8.14M	8.12M	8.12M	7.26M	8.14M	7.26M	5.94M
EPS (Basic)	-0.23	-0.17	-0.18	-0.19	-0.20	-0.23	-0.32	-0.49	-0.53	-0.39	-0.44	-0.41	-0.41	-0.65	-0.55	-0.70	-5.55	-0.52	-0.51	-0.49	-0.53	-0.46
EPS (Diluted)	-0.23	-0.17	-0.18	-0.19	-0.20	-0.23	-0.32	-0.49	-0.53	-0.39	-0.44	-0.41	-0.41	-0.65	-0.55	-0.70	-5.55	-0.52	-0.51	-0.48	-0.53	-0.46
EBITDA	-3.14M	-2.21M	-2.34M	-1.81M	-2.03M	-2.28M	-3.24M	-4.91M	-5.31M	-3.92M	-5.63M	-5.99M	-4.12M	-5.06M	-4.45M	-5.65M	-3.69M	-4.16M	-3.59M	-3.89M	-3.77M	-2.69M
EBIT	-3.16M	-2.3M	-2.43M	-2.05M	-2.06M	-2.3M	-3.27M	-4.94M	-5.34M	-3.96M	-5.67M	-6.04M	-4.17M	-5.11M	-4.5M	-5.7M	-3.74M	-4.21M	-3.69M	-3.94M	-3.82M	-2.74M
Depreciation & Amortization	24K	91K	91K	239K	21K	25K	28K	30K	33K	35K	40K	53K	47K	49K	48K	47K	44K	46K	97K	50K	47K	45K